ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,206Medicare Part D Prescriptions Filled, Including Refills

Rank: 180 out of 2094

$813K Total Retail Price of All Prescriptions

Rank: 164 out of 2094

199 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
94% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 199 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

14% of this provider’s 199 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

1% of this provider’s 9,761 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

52% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$80 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

51 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
METOPROLOL SUCCINATE 352 343 1 9
ATORVASTATIN CALCIUM 350 341 2 5
CRESTOR 280 261 3 15
AMLODIPINE BESYLATE 265 253 4 2
LOVAZA 259 258 5 53
SIMVASTATIN 248 229 6 1
WARFARIN SODIUM 247 240 7 11
ZOLPIDEM TARTRATE 240 234 8 14
LEVOXYL 212 198 9 130
NEXIUM 210 210 10 16
CYMBALTA 175 164 11 61
LISINOPRIL 169 166 12 7
LIPITOR 166 162 13 39
SERTRALINE HCL 164 148 14 26
DIOVAN 158 158 15 13
DIOVAN HCT 152 143 16 28
PRAVASTATIN SODIUM 152 150 16 18
HYDROCHLOROTHIAZIDE 144 138 18 12
OMEPRAZOLE 143 125 19 4
METFORMIN HCL 142 133 20 8
ATENOLOL 131 130 21 21
ESCITALOPRAM OXALATE 128 128 22 46
PLAVIX 123 117 23 38
TAMSULOSIN HCL 116 116 24 29
ACTONEL 115 115 25 151
JANUVIA 114 114 26 35
LEVOTHYROXINE SODIUM 113 102 27 3
LEXAPRO 109 108 28 180
FLUTICASONE PROPIONATE 107 97 29 41
RAMIPRIL 106 106 30 48
DOXAZOSIN MESYLATE 100 97 31 120
FUROSEMIDE 99 99 32 6
CARVEDILOL 96 88 33 19
METHOCARBAMOL 94 76 R 34 433
METOPROLOL TARTRATE 92 84 35 10
BENICAR HCT 91 91 36 133
DONEPEZIL HCL 91 83 36 20
AMITIZA 91 91 36 239
ISOSORBIDE MONONITRATE ER 90 90 39 57
NAMENDA 89 89 40 32
SINGULAIR 83 83 41 64
POTASSIUM CHLORIDE 82 82 42 24
GLIMEPIRIDE 74 74 43 31
CLOPIDOGREL 74 59 43 22
BYSTOLIC 72 72 45 83
CREON 72 72 45 219
LANSOPRAZOLE 61 61 47 144
TRICOR 58 54 48 99
MECLIZINE HCL 57 56 49 103
IBANDRONATE SODIUM 55 55 50 140
DIGOXIN 54 54 51 51
NIASPAN 53 50 52 145
EXELON 53 53 52 111
LOSARTAN POTASSIUM 51 51 54 17
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 28, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.